Women with endometriosis face roughly double the risk of developing systemic lupus erythematosus (SLE) compared with women without it, and the link appears to run deeper than coincidence. Large cohort studies and a recent Mendelian randomization analysis suggest the connection is partly causal, rooted in overlapping immune dysfunction, shared autoantibody patterns, and hormonal drivers that fuel both conditions. The relationship is complex enough that having one diagnosis should prompt awareness of the other, but not so straightforward that a simple shared gene or pathway explains everything.
How Strong Is the Statistical Link
The clearest picture comes from population-level data. A large Taiwanese cohort study tracked women with and without endometriosis over time and found that the endometriosis group developed lupus at roughly three times the rate of the comparison group. The risk was particularly high for women between 30 and 45, who showed an even steeper increase.1PubMed Central. Association between endometriosis and risk of systemic lupus erythematosus A 2024 meta-analysis pooling multiple cohort studies confirmed the direction of that finding, reporting that endometriosis raised the relative risk of lupus by about 77 percent. That same study went further, using a genetic technique called Mendelian randomization to test whether the relationship was likely causal rather than just correlational. The genetic analysis pointed toward a genuine causal effect, with a genetic predisposition to endometriosis almost doubling the odds of developing lupus.2PubMed Central. Causal effects of endometriosis on SLE, RA and SS risk: evidence from meta-analysis and Mendelian randomization
These are not small, speculative signals. A systematic review published in 2023 characterized the association between endometriosis and lupus as “strong,” noting that the link sits within a broader pattern of autoimmune diseases clustering with gynecological conditions. Rheumatoid arthritis and Sjögren syndrome show similar, if less pronounced, associations with endometriosis.3PubMed Central. The Comorbidity of Endometriosis and Systemic Lupus Erythematosus: A Systematic Review The finding that autoimmune conditions tend to travel together in reproductive-age women is not new, but the specific endometriosis-lupus pair has drawn increasingly focused attention over the past decade.
Immune Pathways That Both Conditions Share
At a cellular level, endometriosis and lupus look more alike than you might expect for conditions that affect very different parts of the body. Both involve immune systems that fail to clean up tissue where it does not belong. In endometriosis, endometrial-like tissue grows outside the uterus and is not effectively cleared by the immune system. In lupus, the immune system produces antibodies that attack the body’s own cells and tissues. The overlapping failures occur at several points in the immune chain.
Regulatory T cells, which normally act as brakes on immune overreaction, behave abnormally in both conditions. In women with endometriosis, researchers have found increased numbers of highly active regulatory T cells and macrophages in peritoneal fluid, the liquid that bathes the pelvic organs. At the same time, the balance between different types of helper T cells is disrupted in the endometrial lining itself.4PubMed Central. Epigenetic regulation and T-cell responses in endometriosis – something other than autoimmunity Lupus has its own well-documented T-cell dysfunction, and the overlap in immune-cell behavior likely explains part of why the two conditions co-occur more than chance would predict.
Beyond T cells, both diseases feature elevated inflammatory signaling molecules, reduced programmed cell death (the body’s normal way of clearing unwanted cells), and a chronic inflammatory state that feeds on itself. A 2025 review of the genetics behind the co-occurrence noted that endometriosis and lupus share underlying molecular and cellular pathways, though the exact genes responsible are still being mapped.5PubMed Central. Co-Occurrence of Endometriosis with Systemic Lupus Erythematosus: Genetic Aspects An older but frequently cited review similarly flagged elevated cytokines, decreased programmed cell death, and abnormal cell-mediated immunity as hallmarks common to both.6Autoimmunity Reviews. Is there an association between autoimmunity and endometriosis?
Autoantibodies Show Up in Endometriosis Too
One of the most striking pieces of evidence for immune overlap is the presence of antinuclear antibodies (ANA) in women with endometriosis. ANA are the signature screening marker for lupus and other connective-tissue diseases. They should not be particularly common in a gynecological condition, but they are. A cross-sectional study of 94 endometriosis patients found a 21 percent rate of positive ANA, compared with about 5 percent in controls. Interestingly, the more specific lupus markers like anti-double-stranded DNA antibodies were absent, which suggests a milder or different form of autoimmune activation rather than full-blown lupus.7PubMed. Antinuclear antibodies in patients with endometriosis: A cross-sectional study in 94 patients
A separate study found a similarly elevated ANA rate of about 26 percent in women with endometriosis versus 10 percent in controls. That study also found significantly higher rates of lupus anticoagulant and anti-thyroid peroxidase antibodies in the endometriosis group, pointing to a broader autoimmune tendency that extends beyond just lupus-related markers.8Crescent Journal of Medical and Biological Sciences. Evaluating the Role of Autoimmunity in Endometriosis Patients For clinicians, the practical takeaway is that a positive ANA in a woman with endometriosis does not automatically mean lupus. But it does signal that her immune system is running in a pattern that raises the probability of autoimmune conditions developing down the line.
The Estrogen Factor
Both endometriosis and lupus are diseases that overwhelmingly affect women of reproductive age, and estrogen is a major reason why. Endometriosis is explicitly estrogen-dependent: the displaced tissue grows in response to estrogen just like the uterine lining does, which is why treatments for endometriosis often aim to suppress estrogen levels. Lupus, meanwhile, is about nine times more common in women than men, with onset typically peaking during peak reproductive years when estrogen levels are highest.
Estrogen does more than just influence tissue growth. It modulates the immune system in ways that can tip the balance toward autoimmunity. Estrogen tends to boost antibody production and enhance certain inflammatory immune responses. In women who are genetically susceptible, this hormonal environment can push the immune system from quiet surveillance toward active self-attack. The Taiwanese cohort study noted that the association between endometriosis and lupus was strongest in the 30-to-45 age bracket, which aligns neatly with the period of highest and most sustained estrogen exposure.1PubMed Central. Association between endometriosis and risk of systemic lupus erythematosus
This shared hormonal driver also creates treatment dilemmas. Hormonal therapies for endometriosis, particularly those that suppress estrogen, can theoretically reduce lupus flare risk, but the reverse can also be true: hormone replacement therapy after menopause in a woman with both conditions requires careful weighing of endometriosis recurrence against lupus activity. A consortium of European medical societies recently developed specific eligibility criteria for menopausal hormone therapy in women with endometriosis, lupus, and antiphospholipid syndrome, reflecting how real this balancing act is in clinical practice.
Why One Condition Can Mask the Other
If you have endometriosis and start experiencing new fatigue, joint pain, or abdominal discomfort, it is easy to assume that your existing condition is getting worse. Lupus symptoms often mimic or overlap with symptoms that women with endometriosis already deal with. Fatigue is nearly universal in both. Pelvic and abdominal pain could be endometriosis progression or lupus-related serositis, an inflammation of the membranes lining the abdomen and other body cavities. Even kidney involvement in lupus can initially present with vague symptoms that get attributed to something else.
The diagnostic delay problem runs both ways. A woman whose lupus presents primarily with fatigue and pelvic pain might get evaluated for endometriosis years before anyone suspects an autoimmune process. Conversely, a woman with diagnosed endometriosis whose inflammatory markers are chronically elevated might not trigger alarm bells when those markers drift higher due to emerging lupus.
One revealing finding from the cohort data is that women with endometriosis who were not taking corticosteroids had a dramatically higher hazard of developing lupus compared with the overall endometriosis group. The adjusted risk in corticosteroid-free participants was over nine times higher.1PubMed Central. Association between endometriosis and risk of systemic lupus erythematosus That finding suggests corticosteroids used for other reasons may have been incidentally suppressing lupus development in some women, essentially masking an autoimmune process that would have otherwise become clinically apparent. It also raises the possibility that the true association between the two conditions is even stronger than the headline numbers suggest, because some cases are being pharmacologically suppressed without anyone realizing it.
The Antiphospholipid Connection
Lupus and endometriosis share yet another troubling overlap: antiphospholipid syndrome (APS), a clotting disorder driven by specific autoantibodies. APS can cause blood clots, recurrent miscarriage, and other pregnancy complications. It frequently co-occurs with lupus, but recent data show it also tracks with endometriosis independently. Women with endometriosis have roughly a 2.8-fold higher risk of developing APS compared with women without endometriosis.9PubMed. Genetic factors associated with the co-occurrence of endometriosis with antiphospholipid syndrome (Review)
This matters in a very practical way. If you have endometriosis and are planning a pregnancy, the elevated risk of APS means a higher baseline risk of pregnancy complications that might not be on your obstetrician’s radar unless someone connects the dots. The presence of lupus anticoagulant (one of the key APS antibodies) was found at nearly six times the rate in endometriosis patients compared with controls in one study.8Crescent Journal of Medical and Biological Sciences. Evaluating the Role of Autoimmunity in Endometriosis Patients Screening for these antibodies is not currently standard practice for endometriosis patients, but as the evidence mounts, that may change.
Hydroxychloroquine as a Potential Treatment Bridge
One of the more intriguing treatment overlaps involves hydroxychloroquine (HCQ), a drug that has been a mainstay of lupus management for decades. HCQ modulates the immune system without heavily suppressing it, reduces flares, and protects against organ damage in lupus. Researchers have begun investigating whether it could also help with endometriosis, given the shared immune dysfunction.
In a mouse model of endometriosis, HCQ reduced the number of endometriotic lesions and disrupted their tissue structure. It also increased peritoneal macrophage activity and boosted levels of a specific immune signaling molecule involved in clearing abnormal tissue. The drug appeared to work by interfering with autophagy, a cellular recycling process that endometriotic cells may exploit to survive in locations where they should not.10PubMed Central. Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis This is still preclinical work, and mouse findings do not always translate to humans. But for women who already take HCQ for lupus and also have endometriosis, there is at least a biological rationale to suspect the drug may be helping both conditions simultaneously.
Chronic Pain, Sensitization, and the Overlap With Fibromyalgia
Both endometriosis and lupus are associated with chronic pain that can outlast the inflammatory activity driving it. A concept called central sensitization helps explain why: when the nervous system is bombarded by pain signals for months or years, it can become permanently more responsive, amplifying pain even when the original source has stabilized or been treated. This phenomenon underlies fibromyalgia, which is increasingly recognized as a frequent companion to both conditions.
Fibromyalgia prevalence is elevated in lupus, in endometriosis, and in a range of other chronic inflammatory conditions. A review of the literature found that fibromyalgia clusters with what researchers call central sensitivity syndromes, a family of overlapping chronic pain conditions that includes irritable bowel syndrome, chronic fatigue syndrome, and temporomandibular disorders. Lupus and endometriosis both appear on the list of structural-pathology conditions with higher fibromyalgia rates.11Pain Research and Treatment. The prevalence of fibromyalgia in other chronic pain conditions
For someone living with both endometriosis and lupus, this layering effect can make pain management especially difficult. Treatments targeting inflammation alone may not fully resolve pain if central sensitization has set in. Recognizing this overlap early and addressing it with appropriate strategies, rather than simply escalating anti-inflammatory drugs, can make a meaningful difference in quality of life.
How Chronic Stress Feeds the Cycle
Living with a painful chronic illness is inherently stressful, and chronic stress itself worsens autoimmune disease. This is not a vague mind-body claim; the mechanism is well documented. Prolonged stress disrupts the body’s main stress-response system, leading to cortisol dysregulation. Cortisol normally acts as a brake on inflammation. When that brake stops working properly, inflammatory signals run unchecked, creating an environment that favors autoimmune flares. Research links persistent stress-axis dysfunction specifically to lupus, rheumatoid arthritis, and multiple sclerosis.12PubMed Central. Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation
For women with endometriosis who are at elevated risk for lupus, this creates a feedback loop worth taking seriously. Endometriosis-related pain and its effects on work, relationships, and mental health generate chronic stress. That stress impairs cortisol regulation and promotes inflammation. The resulting inflammatory state may accelerate the timeline for autoimmune conditions that were lurking beneath the surface. Breaking the cycle with adequate pain management, mental health support, and stress reduction is not just about comfort; it is a plausible strategy for reducing autoimmune risk.
The Gut Microbiome as an Emerging Link
Endometriosis frequently comes with digestive symptoms, including bloating, pain with bowel movements, and irritable-bowel-like patterns, that lead many women to receive a gastrointestinal diagnosis before anyone identifies the endometriosis itself. Researchers have begun examining whether the gut microbiome, the community of bacteria living in the digestive tract, plays a role in both endometriosis and its associated immune dysfunction.
A comprehensive review published in 2025 summarized evidence from animal and human studies showing that women with endometriosis have altered gut bacteria compared with women without the condition. The review described endometriosis as a systemic, immune-mediated condition with multifactorial origins and highlighted a potential two-way relationship between microbiome changes and immune dysregulation.13Microbiome. Microbiota insights in endometriosis Lupus has its own growing body of microbiome research, with studies finding distinct bacterial patterns in people with active disease. Whether the microbiome changes seen in endometriosis contribute to the elevated lupus risk is speculative at this stage, but it is an active area of investigation that could eventually offer new intervention points, potentially through probiotics, diet, or targeted microbiome therapies.
What This Means If You Have One of These Conditions
If you have endometriosis, you do not need to panic about developing lupus. The absolute risk remains low even with the elevated relative risk; lupus is an uncommon disease to begin with. But awareness matters. If you develop new symptoms that do not fit neatly into your endometriosis picture, like joint pain, a facial rash, mouth sores, unusual hair loss, or kidney problems, mention your endometriosis history to whatever doctor you are seeing. The statistical link is strong enough that endometriosis should lower the threshold for lupus screening, particularly ANA testing, when suggestive symptoms appear.
If you have lupus and develop worsening pelvic pain, painful periods, or fertility difficulties, endometriosis is worth considering as a concurrent diagnosis rather than assuming the pain is lupus-related inflammation. The two conditions can coexist and complicate each other, and treatment strategies differ. Hormonal suppression works for endometriosis but needs careful management in lupus. Immunosuppressive drugs used for lupus may or may not address the immune dysfunction underlying endometriosis. The emerging research on hydroxychloroquine is promising but not yet at the stage where it changes clinical practice for endometriosis specifically. For now, the most actionable step is simply knowing that these conditions travel together more often than they should by chance, and making sure your medical team knows it too.